national
FTC and Seven States Seek Contempt Ruling Against Martin Shkreli
Just the facts
The Federal Trade Commission and a coalition of seven states are seeking a contempt of court ruling against pharmaceutical executive Martin Shkreli. Legal filings allege that Shkreli violated a lifetime ban on participating in the pharmaceutical industry that was imposed as a condition of his 2022 release from prison. The motion claims he has continued to involve himself in business decisions and maintained ownership stakes, which were prohibited under the terms of his previous settlement.
Why this is news
The Federal Trade Commission and seven states have filed a motion alleging that pharmaceutical executive Martin Shkreli violated a court-mandated lifetime industry ban.
Sources
This summary is compiled strictly from the original reporting below.